IRIDEX Corp
NASDAQ:IRIX
IRIDEX Corp
Total Receivables
IRIDEX Corp
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRIDEX Corp
NASDAQ:IRIX
|
Total Receivables
$9.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Receivables
$2.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Receivables
$2.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Total Receivables
$3.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Receivables
$6.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Receivables
$1.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
See Also
What is IRIDEX Corp's Total Receivables?
Total Receivables
9.1m
USD
Based on the financial report for Mar 30, 2024, IRIDEX Corp's Total Receivables amounts to 9.1m USD.
What is IRIDEX Corp's Total Receivables growth rate?
Total Receivables CAGR 10Y
3%
Over the last year, the Total Receivables growth was -15%. The average annual Total Receivables growth rates for IRIDEX Corp have been 4% over the past three years , 2% over the past five years , and 3% over the past ten years .